OncologyEducation’s Best of ASCO® Vancouver 2023 Conference is a program licensed by the American Society of Clinical Oncology® and will be a full-day hybrid event on June, 23rd, 2023. Chaired by Dr. Sharlene Gill and Dr. Nancy Nixon, the focus of this event will be to provide medical oncologists and other healthcare practitioners with a summary of the most significant treatment advances presented at The 2023 ASCO® Annual Meeting, with presentations focused on several key disease sites. The Best of ASCO® Vancouver 2023 faculty will draw from some of Canada’s most influential oncologists.
- To summarize the most significant treatment advances presented at The 2023 ASCO® Annual Meeting
- To review the current standard of care for key malignancies
- To discuss the current controversies in the management of specific cancers
Friday, June 23, 2023
8:00 AM – 3:10 PM PT
In Person & Free Virtual Registration Options Below:
Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at email@example.com for registration and sponsorship opportunities.
Join Us Live In Person at the
Westin Bayshore, Vancouver
Times listed are PST
- Timezone: America/New_York
- Date: Friday, June 23, 2023
- Time: 11:00 am - 7:20 pm
8:00 a.m. – 9:45 a.m.
Registration and Breakfast Buffet (in-person)
8:45 a.m. – 8:55 a.m.
Welcome Address – Dr. Sharlene Gill & Dr. Nancy Nixon
8:55 a.m. – 9:40 a.m.
Ipsen Breakfast Symposium: Bridging The Gap: Harnessing Real-World Evidence to Inform Treatment Sequencing in Clinical aRCC Patient Cases – Dr. Christian Kollmannsberger
9:40 a.m. – 10:05 a.m.
Non-Prostate GU Cancer – Dr. Christian Kollmannsberger
10:05 a.m. – 10:30 a.m.
Colorectal GI Cancer – Dr. Jonathon Loree
10:30 a.m. – 10:50 a.m.
Networking Break & Sponsor Exhibits
10:50 a.m. – 11:15 a.m.
Lymphoma – Dr. Kerry Savage
11:15 a.m. – 11:40 a.m.
Melanoma – Dr. Allison Weppler
11:40 p.m. – 12:05 p.m.
Prostate Cancer – Dr. Steven Yip
12:05 p.m. – 12:30 p.m.
Special Session: Palliative Care Difficult Conversations and Advance Care Planning – Dr. Charlie Chen
12:30 p.m. – 1:00 p.m.
Lunch Break and Buffet (in-person)
1:00 p.m. – 1:45 p.m.
Gilead Lunch Symposium: Where Do We Stand with Triple-Negative Breast Cancer? A Case-Based Discussion. – Dr. Nancy Nixon & Dr. Zahi Mitri
1:45 p.m. – 2:10 p.m.
CNS Updates – Dr. Rebecca Harrison
2:10 p.m. – 2:35 p.m.
Gynecological Updates – Dr. Yvette Drew
2:35 p.m. – 2:55 p.m.
Non-Colorectal GI Cancer – Dr. Patricia Tang
2:55 p.m. – 3:20 p.m.
Networking Break & Sponsor Exhibits
3:20 p.m. – 3:45 p.m.
Lung Cancer – Dr. Barbara Melosky
3:45 p.m. – 4:10 p.m.
Breast Cancer – Dr. Anil Abraham Joy
4:10 p.m. – 4:20 p.m.
Closing Remarks – Dr. Sharlene Gill & Dr. Nancy Nixon
About the Faculty
Dr. Sharlene Gill
Dr. Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver. She received a Bachelor’s of Science in Pharmacy and an MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Master’s of Public Health from the Harvard School of Public Health. In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina. She is actively engaged in education and research, with over 100 peer-reviewed publications and book chapters to her credit. Dr. Gill currently serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee, and is President-Elect for the Canadian Association of Medical Oncologists.
Dr. Nancy Nixon
Dr. Nancy Nixon received a degree in biochemistry with honours from the University of Calgary in 2008 prior to medical school which she completed in 2011. She did her internal medicine and medical oncology specialization training in Calgary, finishing in 2016. In 2017, Dr. Nixon completed a clinical and research fellowship in breast cancer under the supervision of Dr. Sunil Verma. She is currently a full time medical oncologist at the Tom Baker Cancer Centre and Assistant Professor at the University of Calgary. Since 2019 she has been the Southern Alberta Tumour Team Lead for medical oncology. In 2017 she received an Early Career Research Program Award from the Canadian Institute of Health Research, and was featured in the Alberta Cancer Foundation’s LEAP magazine for her research focusing on patient priorities in cancer research. Dr. Nixon is also involved with translational research studies at the University of Calgary examining biomarkers for tumour response to treatment and immune therapies. She has received over $1, 500, 000.00 CAD funding for her research endeavors over since taking on her current position at the Tom Baker. Apart from her clinical and research duties Dr. Nixon is also team captain for the Tom Baker Cancer Conquerors in the Alberta Ride to Conquer Cancer, who have raised close to $1 million in research funds for the Tom Baker since 2016.
For sponsorship-related inquiries, please contact Bernadette Gregoris at firstname.lastname@example.org.
ASCO® is a registered trademark of the American Society of Clinical Oncology. All rights reserved.